malago logo    Home    About Us    Forum    Portal

Freemium Info


Recent News
Immigration
Overstayer
Crimes & Violence
Illegal Activity
Phil/Government
Work/Company
Marriage
Others
Technology
Pinoy Community
Pinoy News
Accidents & Incidents
Nikkeijin (JaPinoy)
Health Issue
Family Feud
Carework
Sex Offenders
Drug Violation
Minors Crimes
Visa Issue
Divorce
Showbiz
Singapore




Nanay at dalawang bata, natagpuang walang malay sa kuruma (04/10)
600 pirasong melon, ninakaw sa taniman (04/09)
Brazilian na lalaki, huli sa attempted murder charge (04/09)
3 Cambodian, huli sa pagnakaw ng solar power cable (04/09)
Pinoy, huli sa pananaksak at pagpatay sa kababayan din natin (04/09)


7.2 Billion Yen, inilaan sa coronavirus vaccine research

May. 22, 2020 (Fri), 515 views


For your documents translation, contact us here in MALAGO.


Ayon sa news na ito, nagbigay ng 7.2 Billion Yen ang Japan Ministry of Health sa 4 na company corporations at limang universities na nagsasagawa ng research and development para sa mabisang vaccine laban sa coronavirus.

Ang apat na company na nabigyan ng financial assistance ay ang ID Pharma located in Tokyo, Shionogi Pharmaceutical in Osaka, KM Biologics in Kumamoto, at AngGes MG also in Osaka.

Ang limang universities naman ay ang Keio University, Tokyo University, Nagasaki University, Niigata University at Tokyo Metropolitan Institute of Medical Science. Iba iba ang amount na ibinigay sa mga ito na umabot sa total na 7.2 Billion Yen. Ang perang ito ay mula sa budget na 10 Billion Yen na inilaan ng Japan Ministry of Health para sa nasabing activity.

Sa ngayon, sa 9 na company at university na nabanggit, ang AnGes MG with joint research with Osaka University ay mag-sasagawa na ng clinical test ng kanilang na developed na vaccine sa darating na JULY ayon din sa news.



BC, MC, Cenomar, Red Ribbon, etc. application in PSA/DFA, click here.


Have problem creating your SPA, Authorization Letter, Affidavit, etc. click here.


Need application form for visa application & other legal documents, click here.